CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
67 hedge funds and large institutions have $80M invested in Cellular Biomedicine Group, Inc. in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-6
Holders Change %
-8.22%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
28
Reduced
15
Closed
12
Calls
$529K
Puts
$1.64M
Net Calls
-$1.11M
Net Calls Change
-$420K
Top Buyers
| 1 |
AGM
1
Alpine Global Management
New York
|
$2.2M |
| 2 |
2
Morgan Stanley
New York
|
$2.47M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$3.2M |
| 4 |
GCIA
4
Gabelli & Co Investment Advisers
Rye,
New York
|
$1.21M |
| 5 |
GF
5
Gabelli Funds
Rye,
New York
|
$1.18M |
